NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1336168624 MD
Verify on CMS → Phillip Calenda, MD
Ophthalmology Physician in Cortlandt Manor, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,082 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 622 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
39%
generic claims · 61% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · Exceptional
Industry payments
$299.55
9 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Phillip Calenda, MD reported a CMS MIPS final score of 100/100 - above the 83.1 national average - and filed 3,048 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 3K
- Part D claims, 2023
- 39%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Phillip Calenda, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Phillip Calenda, MD sits
This provider among ophthalmology physician peers
Across the 9,866 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Phillip Calenda, MD writes more Part D claims than 86% of them and scores higher on MIPS quality than 85% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Phillip Calenda, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Phillip Calenda, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Phillip Calenda, MD?
High performer (top quartile)Primary specialty
Ophthalmology Physician
Medicare Part D claims
3,048 115% vs specialty avg
MIPS final score
100/100 16.9 pts vs avg
Specialty distribution in New York
How Ophthalmology Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Phillip Calenda, MD's 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) - 100/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Phillip Calenda, MD appears in the CMS NPPES registry as an Ophthalmology Physician provider holding MD credentials at 1985 CROMPOND RD, Cortlandt Manor, NY, 10567, with a listed phone of (914) 736-1100. NPI 1336168624 was issued on 07/18/2006.
Medicare Part D records for calendar year 2023 show 3,048 prescription claims written by this provider, covering 622 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 61% brand-name and 39% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 86.8), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,082 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1336168624 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/18/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
100
Final Score
Avg: 83.1
86.8066
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Phillip Calenda, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Ophthalmic Consultants OF Long Island
Hawthorne, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Phillip Calenda, MD. Source: openpaymentsdata.cms.gov.
Total received
$300
Largest payer
SUN PHARMACEUTICAL INDUSTRIES INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Phillip Calenda, MD. To verify Phillip Calenda, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Phillip Calenda, MD - brand share 61.0%
Ophthalmology Physician average
61% brand-name claims vs 39% generic, on 3,048 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
3,048
Total Claims
$1.1M
Total Drug Cost
622
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,480
- Total Day Supply
- 126,118
- Brand vs Generic
- 61% brand / 39% generic
- Brand Drug Cost
- $1.1M
- Generic Drug Cost
- $47K
- Antibiotic Claims
- 11
Patient Demographics
- Average Patient Age
- 74.8 years
- Avg HCC Risk Score
- 1.27
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 42, 65-74: 282, 75-84: 215, 85+: 83
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Phillip Calenda, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
851 claims
- Restasis
Restasis
477 claims
- Lumigan 320
Lumigan
320 claims
- Xiidra 306
Xiidra
306 claims
- Moxifloxacin 203
Moxifloxacin
203 claims
- Prednisolone Acetate 203
Prednisolone Acetate
203 claims
- Cyclosporine 125
Cyclosporine
125 claims
- Timolol Maleate 95
Timolol Maleate
95 claims
| Drug | Claims |
|---|---|
| Latanoprost | 851 |
| Restasis Cyclosporine | 477 |
| Lumigan Bimatoprost | 320 |
| Xiidra Lifitegrast | 306 |
| Moxifloxacin Moxifloxacin Hcl | 203 |
| Prednisolone Acetate | 203 |
| Cyclosporine | 125 |
| Timolol Maleate | 95 |
| Combigan Brimonidine Tartrate/Timolol | 61 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 61 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Phillip Calenda, MD fits within the Ophthalmology Physician landscape nationally.
22,082
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider
Phillip Calenda, MD's 3,048 claims are above the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Calenda.
Dr. Aliaa Abdelhakim Hamed
M.D., PH.D.
New York, NY
Dr. Majida Abdul Gaffar
M.D.
Hawthorne, NY
Dr. David H Abramson
MD
New York, NY
Dr. Frank Accardi
MD
New York, NY
Dr. Jacob Ackerman
MD
Brooklyn, NY
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is Phillip Calenda, MD's specialty? ▼
Phillip Calenda, MD specializes in Ophthalmology Physician and practices in Cortlandt Manor, New York. Credentials: MD.
How much does Phillip Calenda, MD prescribe under Medicare Part D? ▼
In 2023, Phillip Calenda, MD wrote 3,048 Medicare Part D claims totaling $1.1M in drug costs for 622 beneficiaries.
What is Phillip Calenda, MD's Medicare quality score? ▼
Phillip Calenda, MD has a CMS MIPS Final Score of 100/100 (Quality: 86.8). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Phillip Calenda, MD located? ▼
Phillip Calenda, MD is located at 1985 CROMPOND RD, Cortlandt Manor, NY, 10567. Phone: (914) 736-1100.
What is Phillip Calenda, MD's NPI number? ▼
Phillip Calenda, MD's National Provider Identifier (NPI) is 1336168624, issued on 07/18/2006.
Does Phillip Calenda, MD prescribe more brand-name or generic drugs? ▼
Phillip Calenda, MD's prescribing is 61% brand-name and 39% generic drugs by claim count, with $1.1M in brand drug costs.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,082 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does Phillip Calenda, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Phillip Calenda, MD's most frequently prescribed drugs include Latanoprost, Restasis, Lumigan. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Phillip Calenda, MD accept Medicare? ▼
Phillip Calenda, MD appears in CMS Medicare data with 3,048 Part D claims and 622 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Phillip Calenda, MD's credentials? ▼
Phillip Calenda, MD's NPI is 1336168624 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.